Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Insulin Classification and Usage

Types of Insulin

  • The American Diabetes Association classifies exogenous insulins into four main categories based on their duration of action: rapid-acting analogs, short-acting insulin, intermediate-acting insulin, and long-acting analogs 1
  • Rapid-acting analogs, such as insulin lispro, insulin aspart, and insulin glulisina, have an onset of 0.25-0.5 hours, peak of 1-3 hours, and duration of 3-5 hours 2
  • The American Diabetes Association maintains a clear distinction between rapid-acting analogs and human regular insulin as a separate category of "short-acting" insulin 3

Insulin Formulations

  • Premixed insulins contain predetermined proportions of intermediate-acting insulin mixed with short-acting or rapid-acting insulin, such as 70% NPH/30% regular, 50% NPH/50% regular, 75% NPL/25% insulin lispro, and 50% NPL/50% insulin lispro 4
  • These formulations reduce the number of injections required by providing both rapid-acting and intermediate-acting components in a single formulation 4

Storage and Handling

  • Unused vials should be refrigerated, and extreme temperatures (<2°C or >30°C) and excessive agitation should be avoided 4
  • In-use insulin can be stored at room temperature to limit local irritation at the injection site 4

Clinical Considerations

  • The American Diabetes Association recommends that pharmacists and healthcare providers not switch insulin species or types without the prescriber's approval and patient notification 4
  • Changing insulin types (long-acting, intermediate, short, or rapid) from one formulation to another should always be done under medical supervision 4